9/28/2026
Psyence BioMed secures exclusive U.S. ibogaine license
Texas Ibogaine Research Corporation to lead U.S. ibogaine drug development.
Topic archive
psyence labs
2 stories
9/24/2026
Psyence Biomedical invests $5M in ibogaine research
Psyence Biomedical's $5M investment aims to advance ibogaine program in the U.S.